Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$0.23 - $0.43 $13,800 - $25,801
-60,003 Reduced 57.73%
43,932 $15,000
Q3 2022

Nov 09, 2022

SELL
$0.38 - $0.53 $38 - $53
-100 Reduced 0.1%
103,935 $39,000
Q2 2022

Aug 11, 2022

SELL
$0.32 - $0.74 $2,675 - $6,187
-8,362 Reduced 7.44%
104,035 $48,000
Q1 2022

May 12, 2022

BUY
$0.41 - $0.7 $18,655 - $31,849
45,500 Added 68.02%
112,397 $56,000
Q4 2021

Feb 11, 2022

SELL
$0.53 - $1.03 $8,661 - $16,832
-16,342 Reduced 19.63%
66,897 $38,000
Q3 2021

Nov 12, 2021

BUY
$1.0 - $1.18 $19,727 - $23,277
19,727 Added 31.06%
83,239 $86,000
Q2 2021

Aug 10, 2021

SELL
$1.01 - $1.58 $87,730 - $137,241
-86,862 Reduced 57.76%
63,512 $76,000
Q1 2021

May 12, 2021

BUY
$1.23 - $5.98 $161,422 - $784,803
131,238 Added 685.82%
150,374 $195,000
Q4 2020

Feb 10, 2021

SELL
$2.09 - $5.18 $14,607 - $36,203
-6,989 Reduced 26.75%
19,136 $70,000
Q3 2020

Nov 12, 2020

BUY
$1.71 - $2.68 $22,879 - $35,858
13,380 Added 104.98%
26,125 $56,000
Q2 2020

Aug 13, 2020

SELL
$1.23 - $2.12 $2,621 - $4,517
-2,131 Reduced 14.33%
12,745 $23,000
Q1 2020

May 13, 2020

SELL
$1.06 - $2.15 $38,372 - $77,830
-36,200 Reduced 70.87%
14,876 $20,000
Q4 2019

Feb 10, 2020

BUY
$1.45 - $2.79 $12,751 - $24,535
8,794 Added 20.8%
51,076 $93,000
Q3 2019

Nov 12, 2019

BUY
$2.12 - $3.31 $45,122 - $70,450
21,284 Added 101.36%
42,282 $122,000
Q2 2019

Aug 09, 2019

BUY
$2.37 - $3.97 $14,319 - $23,986
6,042 Added 40.4%
20,998 $56,000
Q1 2019

May 13, 2019

BUY
$2.33 - $3.79 $15,352 - $24,972
6,589 Added 78.75%
14,956 $38,000
Q4 2018

Feb 06, 2019

BUY
$2.77 - $9.38 $17,924 - $60,697
6,471 Added 341.3%
8,367 $23,000
Q3 2018

Nov 08, 2018

BUY
$5.53 - $11.36 $10,484 - $21,538
1,896 New
1,896 $17,000

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About IDERA PHARMACEUTICALS, INC.


  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.